flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 reduced the risk of clinically important and death from cardiovascular (CV) causes in patients with type 2 diabetes (T2D) and CKD ca. #ERA24 🇸🇪 #Nephpearls https://www.nejm .org/doi/full/10.1056/NEJMoa2403347 FLOW trial Ozempic® (semaglutide injection)

Low adoption of weight loss medications: a comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s

So, you would draw 0.2 ml of the solution to get a precise 20mg dose

Less Common But Important Risks While uncommon, some side effects are more serious and require prompt medical attention

A label on the front of the package says it is high in protein, has 3 grams of fiber and is "GLP-1 Friendly." "I'm interested in turning it around and seeing what their definition of 'GLP-1 Friendly' is," Wiseman says, flipping the box over and scouring the ingredients listed on the back, listed in order of prominence

doi:10.2337/dc16-1580

Specificity was somewhat lower in our setting (88.9% [16/18] vs 100% [107/107])